Publication:
An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.

dc.contributor.authorDoña, I
dc.contributor.authorCaubet, J C
dc.contributor.authorBrockow, K
dc.contributor.authorDoyle, M
dc.contributor.authorMoreno, E
dc.contributor.authorTerreehorst, I
dc.contributor.authorTorres, M J
dc.date.accessioned2024-02-08T14:41:21Z
dc.date.available2024-02-08T14:41:21Z
dc.date.issued2018-05-10
dc.description.abstractAdverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated (allergy) or non-immunologically mediated. The high number of DHRs that are unconfirmed and often self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs. Primary care physicians are often the first point of contact for the sufferer of a reaction, as such they have a key role in deciding whether to discard the diagnosis or send the patient for further investigation. In this review, we highlight the importance of diagnosing DHRs, analysing in detail the role of primary care physicians. We describe the common patterns of DHRs and signs of its progression, as well as the indications and contraindications for referring the patient to an allergist. The diagnostic process is described and the possible tests are discussed, which often depend on the drug involved and the type of DHR suspected. We also describe recommendations regarding the avoidance of medication suspected to have caused the reaction and the use of alternatives.
dc.format.page16es_ES
dc.format.volume8es_ES
dc.identifier.doi10.1186/s13601-018-0202-2
dc.identifier.issn2045-7022
dc.identifier.journalClinical and translational allergyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/12466
dc.identifier.pubmedID29760877es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17596
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAnaphylaxis
dc.subjectBetalactam
dc.subjectDrug allergy
dc.subjectDrug provocation test
dc.subjectExanthem
dc.subjectHypersensitivity
dc.subjectNon-steroidal anti-inflammatory drugs
dc.subjectSkin test
dc.subjectUrticaria
dc.titleAn EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files